People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Indapta Therapeutics Inc. | — | Pharma | Series C | $84.4M | $289.6M | 2022 |
| Elevation Oncology, Inc. | — | Pharma | Series C | $70.5M | $2.0B | 2019 |
| SonoThera, Inc. | — | Biotechnology | Series B | $30.4M | $550.2M | 2022 |
Lori Hu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lori Hu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Asish Xavier | 1 | 18 |
| Brian Halak | 1 | 10 |
| Richard Gaster | 1 | 7 |
| Steven Elms | 1 | 5 |
| Michael Davidson | 1 | 4 |
| Ronald Martell | 1 | 4 |
| Colin Walsh | 1 | 3 |
| Mark Frohlich | 1 | 3 |
| Andrew Phillips | 1 | 3 |
| GUY DIPIERRO | 1 | 2 |
| Fabio Pucci | 1 | 2 |
| Michael Caldwell | 1 | 2 |
| Kenneth Greenberg | 1 | 2 |
| Timothy Clackson | 1 | 2 |
| Tom Willis | 1 | 2 |
| Laura Stoppel | 1 | 1 |
| Shawn Leland | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.